nature neurOSCIenCe a r t I C l e S Brain activity increases cerebral blood flow using a feed-forward mechanism that is independent of energy consumption. Enhanced release of glutamate from excitatory neurons is thought to induce vessel dilation through three potential signaling pathways (for reviews see refs. 1-3). The 'neuron to arteriole' hypothesis posits that a glutamate-evoked rise in intracellular Ca 2+ concentration ([Ca 2+ ] i ) in postsynaptic dendrites triggers the release of vasodilators and potassium. The 'astrocyte to arteriole' hypothesis suggests that glutamatergic activation of metabotropic glutamate receptor 5 (mGluR5) in astrocytes triggers a rise in [Ca 2+ ] i , leading to the release of arachidonic acid and vasoactive metabolites. Recently, a 'pericyte to capillary' hypothesis 4,5 has been proposed to occur at the level of first-order capillaries, involving a local prostaglandin E 2 -mediated dilation that precedes arteriole dilation 6 .
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The contribution of each pathway to functional hyperemia remains unresolved, as large mechanistic differences have been reported across brain regions. These divergent findings may result from region-or synapse-specific characteristics, as well as methodological differences, such as the stimulus parameters, the type and level of anesthesia 7 or the pharmacological approach. In particular, the involvement of astrocytes has recently been called into question. Several studies have reported that Ca 2+ transients evoked in astrocytes in response to neuronal activity are rare and delayed relative to the onset of functional hyperemia [8] [9] [10] [11] . However, these studies monitored Ca 2+ signals in astrocyte cell bodies rather than their processes, from which vasoactive compounds are presumably released 12 . There is considerable evidence, from experience using chemical 13, 14 and genetically encoded 15, 16 Ca 2+ sensors, that Ca 2+ signals in astrocytes are highly compartmentalized and that activity in discrete regions of their processes, termed microdomains, are often uncorrelated with events that occur in the soma. These results suggest that astrocyte Ca 2+ dynamics may be more heterogeneous and complex than previously assumed [17] [18] [19] and that activity in microdomains could be subject to local independent modulation 20 . The role of astrocytic mGluR5 signaling in triggering functional hyperemia has also been challenged, as application of mGluR5-selective antagonists failed to affect functional hyperemia 21 and mGluR5 expression is strongly downregulated in adult mice 22 . In addition, functional hyperemia persists in IP 3 R2-knockout mice 11, 23 , and IP 3 R2 is required for metabotropic receptor-induced Ca 2+ signaling in astrocytes 24 .
The olfactory bulb glomerulus is a small neural network ideal for studying neurovascular coupling because of its accessibility, well-defined circuitry and ability to be activated by defined stimuli. Nevertheless, the respective roles of astrocytes and local neurons in controlling blood flow in this region are controversial [25] [26] [27] . In particular, the role of postsynaptic neurons has been difficult to assess because of the dense dendrodendritic synaptic connectivity 28 , the expression of mGluR5 on juxtaglomerular (JG) cell dendrites 29, 30 and the diversity of these cells 31 . The role of astrocytes also remains unresolved owing to the restriction of previous imaging studies to their somatic responses. Here, we revisited the role of Ca 2+ signaling in astrocytes upon activation of olfactory sensory neuron (OSN) terminals in both acute slices and in vivo. Using acute slices from juvenile Aldh1l1-eGFP mice loaded with the Ca 2+ indicator Rhod-2, we find that stimulation of OSNs evokes Ca 2+ increases in astrocyte somata that involve mGluR5, have a high threshold and occur with a r t I C l e S a delay of several seconds relative to those in neurons. To investigate Ca 2+ signals in mature astrocytes, including in their fine processes, we used adult mice expressing the Ca 2+ sensor protein GCaMP3 (ref. 20) under the conditional control of the connexin 30 promoter 32 . In acute slices from these mice, mGluR5 agonists failed to trigger astrocytic Ca 2+ signals in either somata or processes, although astrocytes still responded robustly to ATP. In vivo, odorants systematically evoked Ca 2+ increases in astrocytes that were restricted to their processes and preceded functional hyperemia by 1-2 s. The spatiotemporal dynamics of these Ca 2+ signals reestablish astrocytes as potential regulators of neurovascular coupling.
RESULTS

Pharmacological activation of Ca 2+ signals in astrocytes
We first analyzed the role of group I mGluRs (mGluR1 and mGluR5) in generating Ca 2+ signals in neurons and astrocytes within the olfactory bulb glomerulus. In acute slices from juvenile (post-embryonic day 14 (P14)-P21) Aldh1l1-eGFP mice 33 incubated with the Ca 2+ indicator Rhod2-AM (Rhod-2), astrocyte somata were co-labeled in red (Rhod-2) and green (eGFP), whereas neuron somata were red (Rhod-2). Because this approach did not allow us to distinguish neuronal from astrocytic processes, quantification of astrocyte Ca 2+ dynamics was limited to somatic signals. Pressure application of the broad-spectrum mGluR agonist trans-1-aminocyclopentane-1,3-dicarboxylic acid (t-ACPD) reliably triggered transient Ca 2+ increases in both astrocyte and neuron somata (Fig. 1) , when AMPA/NMDA receptors, GABA A /GABA B receptors and voltage-gated sodium channels were blocked (Fig. 1a,b) . The specific mGluR5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) strongly inhibited t-ACPD-evoked Ca 2+ responses in astrocytes (Fig. 1a,b) . In JG neurons, the degree of inhibition by MPEP was more variable (Fig. 1b) , in accordance with the known variation in expression of various mGluR subtypes among these neurons 29, 31 . The mGluR1 antagonist CPCCOEt strongly reduced t-ACPD-evoked Ca 2+ responses in neurons but was less effective at inhibiting astrocyte responses (Fig. 1c,d) . These results point to a prominent contribution of mGluR5 to t-ACPD-induced somatic Ca 2+ responses in astrocytes in these juvenile mice. In contrast, the smaller effect of mGluR1 blockade on astrocytes raises the possibility that astrocytes may be responding to an indirect signal mediated by glomerular neurons (for example, dendritic glutamate release triggered by mGluR1 activation).
Synaptic activation of Ca 2+ signals in astrocytes As pressure application of t-ACPD indiscriminately activates synaptic and extrasynaptic mGluRs, we next investigated the physiological activation of mGluRs in response to glutamate release from OSN terminals. In acute slices from juvenile Aldh1l1-eGFP mice, singlepulse stimulation of OSN axons distant from their target glomerulus elicited prolonged Ca 2+ responses in neuronal somata, but not in astrocytes (Fig. 2) . In contrast, astrocyte somata responded only to higher stimulus intensities, and then with a 20-fold longer delay (4.5 ± 0.7 s; n = 16 cells, nine mice) than that of neurons (0.18 ± 0.02 s (mean ± s.e.m.); n = 27 cells, ten mice). This difference in stimulus threshold for astrocytes persisted when trains of stimuli were applied at 20 Hz: brief stimulus trains (0.5 s) evoked Ca 2+ increases in JG neurons only, whereas longer trains (1-2 s) triggered delayed and slowly rising Ca 2+ signals in astrocytes ( Supplementary Fig. 1a-c) . Notably, responsive astrocytes were observed in only 14% of all (Fig. 3a-c) . It also increased the percentage of glomeruli containing responsive astrocytes to 70% (ten glomeruli in ten slices from eight animals). However, these antagonists also caused a persistent increase in resting Ca 2+ levels in all JG neurons (Fig. 3d) , decreased their response to OSN stimulation and eventually induced Ca 2+ oscillations ( Fig. 3b) , presumably by increasing ambient glutamate levels 34 . These results indicate that glutamate transporter inhibition causes substantial changes to the basal state of the glomerular neuronal network and is therefore unsuitable to investigate the input-output function of astrocytes. 
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We next tested the contribution of mGluRs to stimulation-induced Ca 2+ responses in astrocytes and neurons. The mGluR5 antagonist MPEP markedly reduced stimulus-evoked Ca 2+ responses in astrocyte somata (Fig. 4a) but did so less efficiently in neurons, similar to the effects observed for t-ACPD (Fig. 1) . Blockade of mGluR1s with CPCCOEt had variable effects on Ca 2+ signals evoked in both neurons and astrocytes (Fig. 4b) . In JG cells, it ranged from no effect to a full blockade, and although on average there was a significant decrease (Fig. 4e) , it is clear that not all neurons expressed mGluR1s. In astrocytes, Ca 2+ signals were occasionally abolished (reversibly) or delayed, but on average the effect was not significant (Fig. 4d) . Given the high stimulation threshold of somatic Ca 2+ signals in astrocytes (Fig. 2) and assuming mGluR1 is not expressed by these cells 35 , the modulatory effects of CPCCOEt suggest that astrocytes are indirectly activated by glutamate released from glomerular dendrites. Indeed, bath application of the AMPA and NMDA receptor antagonists 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX) and d-2-amino-5-phosphonovalerate (DAPV) decreased or abolished Ca 2+ responses evoked in both JG neurons (abolition in eight of eleven cells) and astrocytes (abolition in six of seven cells) by high-intensity stimulation of OSNs (Fig. 4c) .
Together, these results suggest that generation of somatic Ca 2+ signals in astrocytes in the juvenile mouse olfactory bulb requires activation of postsynaptic neurons, dendritic release of glutamate and activation of mGluR5 on astrocytes (see the schema in Supplementary  Fig. 2 ), in accordance with the rarity and long latency of somatic Ca 2+ signals observed in vivo upon sensory stimulation [8] [9] [10] [11] . However, these studies are limited by the bulk-loading of AM dyes, which hinders selective imaging of astrocytic processes in adults in vivo, and by the relative immaturity of the mice used in our study (a requirement for efficient dye loading in the glomerulus). To overcome these limitations, we sought to visualize Ca 2+ signals in the processes of glomerular astrocytes from adult mice using a genetically encoded Ca 2+ sensor.
Cx30 promoter-driven expression of GCaMP3
To visualize Ca 2+ transients in astrocytes, we expressed a cytosolic form of GCaMP3 (ref. 20) in astrocytes using the astrocyte-specific promoter connexin 30 (Cx30, also known as Gjb6). Cx30 is a gapjunction protein with a late postnatal onset of expression beginning in the second postnatal week and reaching a maximum at approximately 4 weeks after birth 32 . To target GCaMP3 to astrocytes, we crossed Cx30-CreERT2 mice 36 to R26-lsl-GCaMP3 mice 20 . To determine the cellular localization of GCaMP3, we performed immunohistochemical staining of sensor-expressing cells. In uninjected Cx30-CreERT2; R26-lsl-GCaMP3 bitransgenic mice, sensor-expressing (GFP + ) cells were observed very rarely (glomerular layer: five astrocytes, zero neurons; granule cell/external plexiform layers: 10 astrocytes, 18 neurons; internal plexiform layer/rostral migratory stream: 4 astrocytes, 134 neurons; total of 24 slices, n = 3 mice). These results are probably due to slight tamoxifen-independent recombination in Cx30-expressing astrocytes and neuronal precursors 37 .
When we administered 4-hydroxy-tamoxifen (4-OHT) to 2-to 3-month-old Cx30-CreERT2; R26-lsl-GCaMP3 mice and analyzed , we observed GCaMP3 in a large fraction of olfactory bulb astrocytes, as shown by colabeling with S100β (Fig. 5a) . Notably, GCaMP3 was not expressed by neurons in the glomerular layer (n = 4 adult mice) (Fig. 5b,c) . However, by 60 d.p.i. (n = 2 adult mice), a significant population of GCaMP3 + neurons, predominantly granule cells 36 , was apparent (Fig. 5d) . This was expected, as granule cells in the olfactory bulb are continuously generated from Cx30-expressing radial glial cells in the subventricular zone 37 . As a consequence, only mice from between 5 and 11 d.p.i., in which GCaMP3 expression level remained moderate and restricted to astrocytes, were used for functional imaging.
Effects of ATP and mGluR5 agonists in adults
To assess whether astrocytes in adult mice express mGluR5, we focally applied the group 1 mGluR agonist (S)-3,5-dihydroxyphenylglycine (DHPG) to acute olfactory bulb slices prepared from 2-to 3-monthold Cx30-CreERT2; R26-lsl-GCaMP3 mice (n = 7 glomeruli from four mice). In this preparation cell bodies are often visible in the apparent 'middle' of a glomerulus (for example, Fig. 6a regions of interest (ROIs) 2 and 3) if the imaging plane is near the surface of a glomerular boundary (i.e., it includes part of the juxtaglomerular region containing neuron and astrocyte cell bodies). In the presence of CPCCOEt to isolate mGluR5 responses, DHPG failed to elicit Ca 2+ signals in astrocyte somata or their processes (Fig. 6b,d,f) . The inclusion of Alexa 594 in the application solution confirmed the spread of DHPG across the imaging area.
As the visibility and viability of astrocytes in the adult slice preparation can be problematic, we ensured that astrocytes responded to stimulation by subsequent application of ATP, which reliably elicited robust Ca 2+ increases in the somata and processes of glomerular astrocytes (Fig. 6c,d,f) . Trials with spontaneous events (Fig. 6e) were excluded from the analysis presented in Figure 6f . Together, these results suggest that mGluR5 does not contribute to Ca 2+ signaling in adult olfactory bulb astrocytes.
Ca 2+ dynamics in astrocyte processes during odor stimulus
To determine if and when astrocytes are activated by physiological stimulation, we next simultaneously recorded the response of neurons and astrocytes to sensory input in vivo by measuring odor-evoked signals in the glomerulus of adult, anesthetized Cx30-CreERT2; R26-lsl-GCaMP3 mice. Imaging of neuronal Ca 2+ signals was accomplished by introduction of calcium Ruby nano dextran (CaRubyNano) 38 , a high-affinity red Ca 2+ indicator, into OSNs via nose labeling (Online Methods). Imaging was carried out in the superficial part of the glomerular layer (up to 70 µm from the olfactory bulb surface), and ROIs covered the entire center of the glomerulus, largely devoid of neuron and astrocyte cell bodies 39 . The glomerulus was delineated by labeled OSN terminals (red) and astrocyte processes (green). Ca 2+ responses in OSN terminals provided a reliable readout of the onset and time course of odor-evoked postsynaptic neuronal responses and allowed for the alignment of normally imprecise respirationlinked response onsets for averaging 40 . At low temporal and spatial resolution (Online Methods and Fig. 7 legend) , odor-evoked OSN responses as reported by CaRuby-Nano were apparent, but GCaMP3 responses in astrocytes could not be detected (Fig. 7a) . At higher resolution, small but consistent Ca 2+ increases were detected in 
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astrocyte processes in all glomeruli tested ( Fig. 7b-d) . Ca 2+ responses occurred reproducibly at the onset of each odor presentation with intertrial intervals of 3-4 min. The signal-to-noise ratio (SNR) of the responses and the frame rate (4-100 Hz) used to acquire Ca 2+ signals did not allow us to resolve the delay between the neuronal and glial responses or to visualize Ca 2+ transients within individual processes of astrocytes. In contrast, astrocyte somata that were occasionally visible at the periphery of the glomerulus (Fig. 7c) did not respond to the odor stimulus. The short latency and reliability of odor-evoked responses in astrocyte processes suggest that astrocytic Ca 2+ signals could play a role in neurovascular coupling. To determine the timing of odor-evoked astrocytic Ca 2+ signals in relation to functional hyperemia, we imaged OSN terminals and Ca 2+ transients within astrocyte processes while simultaneously monitoring red blood cell (RBC) velocity in glomerular capillaries of Cx30-CreERT2; R26-lsl-GCaMP3 mice. To measure flow, we labeled blood plasma with Texas Red-labeled dextran and performed a broken line scan along the longitudinal axis of the capillary that extended into the glomerular neuropil, where Ca 2+ signals in OSN terminals (labeled in red with CaRuby-Nano) and astrocyte processes (labeled in green with GCaMP3) could be measured. This approach allowed for simultaneous measurements of all three responses at sampling rates of ~1 kHz, with a spatial resolution of 120-170 nm per pixel (Fig. 8a) . As noted above, in every glomerulus where a Ca 2+ response to odor occurred in OSNs, a Ca 2+ increase was also observed in astrocytes (Fig. 8b) . Under these conditions, odor stimuli also induced robust increases in RBC velocity, indicative of functional hyperemia. On average, changes in blood flow occurred 2.7 ± 0.23 s after the onset of OSN responses (Fig. 8c) . Although it was not possible to precisely calculate the onset of astrocyte responses given the limited SNR achieved using the rapid-line-scan protocol, there is evidently only a short delay (0 < t > 100 ms) between OSN and astrocyte response onsets. To conclude, these in vivo findings indicate that odors induce Ca 2+ transients in astrocyte processes within olfactory glomeruli several seconds before the onset of functional hyperemia, providing sufficient time for these cells to participate in local control of blood flow.
DISCUSSION
In this study, we show that neurons and astrocytes in the olfactory bulb of juvenile mice express different types of group 1 mGluRs, with astrocytes expressing primarily mGluR5 and neurons expressing varying amounts of mGluR5 and mGluR1. Although astrocytes in the adult OB no longer express mGluR5, they exhibit reliable calcium responses to odor stimulation in vivo, beginning seconds before the onset of functional hyperemia. Our results emphasize the importance of examining astrocyte processes, in addition to their somata, and reaffirm astrocytes as possible key players in neurovascular coupling. These findings help to resolve a controversy raised by several contradictory reports [25] [26] [27] investigating the role of astrocytes, mGluRs and postsynaptic neurons in neurovascular coupling in the olfactory bulb. The unique synaptic organization of the glomerulus, notably the exceptional density of reciprocal dendrodendritic synaptic contacts, means that physiological activation of OSNs triggers a complex and prolonged cascade of synaptic activity. Consequently, pharmacological manipulation of postsynaptic activity is known to modulate the amount of both glutamate and GABA released upon OSN activation 40 . Gurden et al. 25 used intrinsic optical signals to monitor blood flow in glomeruli and reported that functional hyperemia is independent of both postsynaptic activity and mGluRs, instead involving glutamate transporters. However, a study from our laboratory 27 showed that pharmacological blockade of both glutamate receptors and glutamate release (with tetrodotoxin) within a single glomerulus does not block local neurovascular coupling, implying that the regulation of functional hyperemia occurs at a supraglomerular level.
Furthermore, the widespread pharmacological blockade of postsynaptic glutamate receptors across the entire dorsal bulb abolished functional hyperemia, suggesting that activation of some postsynaptic components is required. Petzold et al. 26 reported that functional hyperemia involves glutamate transporters as well as mGluR5. However, the authors did not investigate the effect of a regional block of postsynaptic activity on functional hyperemia. Lastly, Sun et al. 22 reported that the expression of mGluR5 in astrocytes is developmentally downregulated to minimal levels after the third postnatal week, raising doubt as to the involvement of these receptors in neurovascular coupling. A previous study from the same group implicated mGluR5 in sensory-evoked astrocytic Ca 2+ signals 8 ; however, there was no direct evidence for their presence on astrocytes. Nonetheless, there is evidence for the expression of mGluR5 in olfactory bulb astrocytes from adult rat 35 .
Our results indicate that in juvenile mice, mGluR5 is expressed by both JG neurons and astrocytes. This is in contrast to mGluR1, which probably influences astrocytes only indirectly via their presence on glomerular dendrites. We also show that, in contrast to neurons, somatic Ca 2+ signals in astrocytes are only elicited by extremely strong activation of both OSNs and the postsynaptic glomerular network. We defined neurons as any eGFP-negative cells, although it may be argued that not all astrocytes are labeled in Aldh1l1-eGFP mice. Therefore, when stimulating with puff application of t-ACPD (Fig. 1) , it is possible that some astrocytes may have been mistaken for neurons. However, in response to OSN stimulation (Figs. 2-4) , the dynamics of the two cell populations defined in this manner were clearly different: GFP-negative 'neuronal' responses occurred at much shorter latencies and had faster rise times than those of eGFP-positive 'astrocytes' , regardless of whether single stimuli or stimulus trains were used. Given the similarity of the conclusions from the two stimulus types, we are confident that neuron and astrocyte responses are well separated in our results. Our findings are congruent with several in vivo studies that have examined somatic Ca 2+ signals in astrocytes, which concluded that their rarity and long latencies preclude them from having a role in neurovascular coupling [8] [9] [10] [11] . However, these studies relied on bulk labeling with AM organic Ca 2+ indicators to monitor astrocyte activity, which may not be suitable to monitor activity in fine astrocyte processes 41 . This is important, as recent studies suggest that Ca 2+ transients in astrocytic processes are more frequent and often occur independently from somatic signals 26, 41, 42 . In our experiments using Rhod-2 AM, we found that neuropil responses had a much lower threshold than those from astrocyte somata (data not shown). It is likely that, in addition to OSN terminals and neuron c npg a r t I C l e S dendrites, astrocyte processes contributed to these signals but were not resolvable using bulk labeling. Indeed, in juvenile mice, astrocyte processes are sensitive to single synaptic stimulation 13 , and in adults processes respond to spontaneous neuronal activity 14 . We find that the inhibition of glutamate transporters enhances stimulus-evoked Ca 2+ signals in juvenile astrocyte somata. However, in neurons it also causes a rise in the resting Ca 2+ level and a decrease in evoked Ca 2+ signals. Consequently, if functional hyperemia depended only on astrocyte somatic Ca 2+ signals evoked by glutamate release from OSN terminals and activation of astrocyte mGluR5, one would expect glutamate transporter antagonists to enhance functional hyperemia, but in fact the opposite effect has been reported 25, 26 . Unfortunately, these antagonists induce a rise in extracellular glutamate that leads to sustained activation of glomerular neurons and astrocytes, precluding its use in studying the role of this pathway in functional hyperemia.
In vivo studies using another Ca 2+ indicator dye, Oregon Green BAPTA 1-AM, reported fast synaptically evoked Ca 2+ signals in somata 42, 43 and processes 43 of cortical astrocytes. However, the latter study could not ensure separation of signals from labeled astrocyte processes, axonal terminals and thin dendrites. This issue could be solved by investigating the dynamics of Ca 2+ in astrocyte processes that express genetically encoded Ca 2+ sensors. However, expression of these genes relies on the use of astrocyte promoters, which are also active in glial progenitor cells. Ongoing adult neurogenesis represents a particular challenge for genetic labeling of astrocytes in the OB, as adult-born neurons are continually generated from these precursors 44, 45 . This problem is well demonstrated by the considerable neuronal labeling apparent in GLAST-ERT2; R26-lsl-GCaMP3 mice, which is probably a consequence of the early expression of GLAST in glial precursor cells 46 . To circumvent this problem, we used the postnatally active Cx30 promoter and a tamoxifen-dependent version of Cre recombinase to achieve GCaMP3 expression in astrocytes of adult mice 32, 36 . We observed neuronal expression of GCaMP3 some weeks (~3 weeks) after induction, in accordance with previous observations that Cx30-positive radial glia generate neuroblasts. Nevertheless, astrocyte Ca 2+ dynamics can be visualized selectively in both acute slices and in vivo if imaging is performed shortly after induction of Cre activity in Cx30-CreERT2; R26-lsl-GCaMP3 mice.
We observed that in slices from adult Cx30-CreERT2; R26-lslGCaMP3 mice, application of mGluR5s agonists failed to induce an elevation of astrocytic Ca 2+ . One possibility is that we missed fast calcium elevation; however, the spatiotemporal resolution of our fullframe slice recordings (4 Hz) was sufficient to record spontaneous events restricted to astrocyte processes (Fig. 6e) . This corroborates evidence that expression of mGluR5 is markedly downregulated in adult astrocytes 22 , that functional hyperemia is maintained in IP 3 R2-knockout mice 23, 47, 48 and that basal cortical blood flow is insensitive to selective stimulation of astrocytic Gq-GPCR cascades using the hM3Dq DREADD designer receptor system 48 . Moreover, our results indicate that if mGluR5s are expressed by neurons in adults, their influence is insufficient to trigger astrocytic activation indirectly. Importantly, our in vivo imaging revealed that astrocyte processes, but not their somata, reliably respond to sensory stimulation with a rapid onset that is nearly coincident with that of surrounding neurons. Further, the activation of both OSN terminals and astrocyte processes clearly precedes functional hyperemia by ~1-3 s. Unfortunately, the SNR of our current approach is too low to reliably quantify the relative onset of Ca 2+ signals in OSNs and astrocyte processes. The use of animals expressing Ca 2+ reporter proteins with a better SNR (for example, GCaMP6) or targeted to the membrane 16 may help to reveal the kinetics of responses in these small compartments. Taken together, our results emphasize the importance of imaging the fine processes of astrocytes, as they may more faithfully report synaptic activity, as shown in vitro 13, 14 . We thus demonstrate that astrocytes respond to sensory stimulation with sufficient speed to allow them to play a role in neurovascular coupling. As a result, simultaneous investigation of astrocytes and pericytes 5 , in anesthetized and awake mice, becomes the next challenge to determine the respective roles of these two cell types in the development and regulation of neurovascular coupling and resting vessel tone.
METHODS
Methods and any associated references are available in the online version of the paper. 
